Adsilico

Provider of insilico trials using virtual patients to assess medical device safety

placeLondon, England, United Kingdom calendar_todayFounded 2022 language adsilico.uk

Registered entities

Social engagement

Social engagement: 1.1K social following, 1 post in the last 12 months — below the industry typical range.

Investor mix

4 investors on record; lead investors include Northern Gritstone, Parkwalk.

Investor typeCountShare
Venture capital250%
Other / undisclosed250%

Recent activity

2 Apr 2026
Product launch
Virtual Chimera® technology
Coming soon